A celebratory groundbreaking event marks the beginning of a comprehensive revitalization project of UC San Diegos Hillcrest campus. Construction for the UC San Diego Long Range Development Plan encompasses approximately 60 acres and the redevelopment of the more than 50-year-old campus. Phase 1 includes an approximately 10-acre site. University of California Credit: CallisonRTKL
A celebratory groundbreaking event today marks the beginning of a comprehensive revitalization project of UC San Diegos Hillcrest campus, which upon completion will feature state-of-the-art facilities, expanded patient care services and technologies and other community amenities to promote wellbeing.
Construction for the UC San Diego Long Range Development Planencompasses approximately 60 acres and the redevelopment of the more than 50-year-old campus. Complementing the new academic medical facilities and services will be new housing and fitness facilities.
The reimagined Hillcrest campus will increase access to UC San Diego Healths nationally ranked medical specialties and world-class patient care. The revitalization project will form a modern destination medical center that will further improve the exceptional care and medical education UC San Diego is known to deliver, said UC San Diego Chancellor Pradeep K. Khosla.
Redevelopment construction on the $2.5 to $3 billion project is expected to continue over approximately 15 years in five major phases.
"As the regions only academic medical center, UC San Diego Health brings the most advanced science and patient care to our communities to help people lead healthier, higher quality lives, said Patty Maysent, CEO, UC San Diego Health.
UC San Diego Medical Center in Hillcrest is a hospital with tremendous strength and character, and a rich history. The new Hillcrest campus will underscore our status as a premier health care destination for patients, as well as enhance the experiences of our remarkable staff.
Phase 1 includes a 250,000-square-foot outpatient pavilion anticipated to open in 2025, which will house specialty clinical programs, including oncology, neurosurgery, urology, otolaryngology and orthopedics, as well as ambulatory surgery operating rooms, gastroenterology procedure rooms, advanced imaging, infusion and radiation oncology.
During the groundbreaking ceremony, Price Philanthropies Foundation and the Price family will be recognized for helping inaugurate the fundraising effort for the outpatient pavilion with a $10 million gift.
Robert Price, President of Price Philanthropies, shares his familys motivation for supporting UC San Diego Health.
UC San Diego Medical Center in Hillcrest has been a leader in our community for more than half a century, said Price. This project will significantly increase access to UC San Diego Healths outstanding outpatient and specialty care services for families and others who live south of Interstate 8. We encourage others to join in supporting UC San Diego Health in this vital initiative.
The outpatient pavilion will address the growing demand for specialized diagnostic, treatment and surgical services. More specifically, new and significant space for multispecialty cancer clinics and infusion centers will allow UC San Diego Health, and its National Cancer Institute-designated Comprehensive Cancer Center, to greatly increase access to cancer care throughout the region.
The first phase of redevelopment includes a 250,000-square-foot outpatient pavilion and a 1,850-space parking structure. University of California Credit: CallisonRTKL
Whether for primary care or specialty care, such as cancer, patients come to UC San Diego Health to receive exceptional medical attention and life-saving treatments, said Catriona Jamieson, MD, PhD, professor of medicine at UC San Diego School of Medicine, and director of stem cell research at Moores Cancer Center at UC San Diego Health. The Hillcrest campus project will help ensure San Diegans and their families, friends and neighbors have access to top physicians and the health care they deserve.
The first phase of redevelopment includes a 250,000-square-foot outpatient pavilion and a 1,850-space parking structure. University of California Credit: CallisonRTKL
Whether for primary care or specialty care, such as cancer, patients come to UC San Diego Health to receive exceptional medical attention and life-saving treatments, said Catriona Jamieson, MD, PhD, professor of medicine at UC San Diego School of Medicine, and director of stem cell research at Moores Cancer Center at UC San Diego Health. The Hillcrest campus project will help ensure San Diegans and their families, friends and neighbors have access to top physicians and the health care they deserve.
The first phase of construction also includes a new parking structure to provide approximately 1,850 spaces for employees, patients and visitors, plus related road and utility infrastructure.
Planned upgrades for UC San Diegos Hillcrest campus will be synchronized to reduce impact on the surrounding community while ensuring current, critical campus functions remain operational.
Later phases of the project will include the replacement of the main hospital, which once served as the county hospital. The project is necessary to comply with 2030 seismic safety provisions of the California Hospital Code.
The Hillcrest campus includes a Level 1 Trauma Center, a Regional Burn Center and a Comprehensive Stroke Center. The Emergency Department manages more than 50,000 patient visits per year. Approximately 5,000 nurses, doctors, technicians, staff and administrators serve the needs of the community at the location.
I have worked at UC San Diego Health for many years. The Hillcrest hospital and our superb multi-disciplinary staff have been through many severe flu seasons, the AIDS crisis, wildfire disasters and now the COVID-19 pandemic. We show up for each other and our patients every day, said Ted Chan, MD, chair of the Department of Emergency Medicine at UC San Diego Health.
As our region continues to grow, particularly in the central and south county areas, a new Hillcrest facility will allow us to amplify our advanced care to the community for common illnesses and complex conditions, strengthening our position as the beacon of health care.
The UC San Diego Hillcrest campus is located three miles north of downtown San Diego and 13 miles south of the universitys La Jolla Campus. Historically, it has been a critical regional resource, providing care for all patients, including those in under-insured or uninsured communities.
With its first hospital at the Hillcrest campus in 1966, UC San Diego Health has been a driver of innovation and breakthroughs in medical science and health care, from the regions first kidney transplant in 1968 to testing novel antiviral drugs for treating HIV/AIDS in the 1980s to caring for some of the first patients with COVID-19 in the United States in 2020.
Our vision for the community is to create a healthier world one life at a time through new science, new medicine and new cures, said Maysent. The UC San Diego Hillcrest campus project will reinforce and support that vision and our commitment and dedication to the San Diego region and beyond.
View post:
UC San Diego Breaks Ground on Revitalization of Hillcrest Campus - UC San Diego Health
- Using stem cell-derived heart muscle cells to advance heart regenerative therapy - Medical Xpress - April 28th, 2024
- John Cleese is spending thousands on stem cell therapy is it really the secret to anti-ageing? - Yahoo Lifestyle Australia - April 28th, 2024
- SUM Hospital conducts Odishas first stem cell transplantation - The Times of India - April 24th, 2024
- Cancer treatment: What is stem cell therapy, and how does it work? - Moneycontrol - April 24th, 2024
- The murky, unregulated world of anti-ageing stem cell therapy - The Telegraph - April 24th, 2024
- Drug Prototype Promising in Treatment of Pulmonary Disease - Medscape - April 20th, 2024
- Man Paralyzed In Surfing Accident Regains Ability to Walk After Stem Cell Treatment - The Inertia - April 20th, 2024
- Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV - April 20th, 2024
- Stem Cell Treatment Helped A Man Who Was Paralyzed From The Neck Down To Stand On His Own - Bored Panda - April 20th, 2024
- UM, CUHK jointly hold symposium on stem cells and regenerative medicine - gcs.gov.mo - April 20th, 2024
- Paralysed patient now able to walk as stem cell therapy shows promising results - WION - April 15th, 2024
- Andrew Steele Sees Aging as the Root of Disease - Worth - Worth Magazine - April 15th, 2024
- The astonishing effect of stem cell implants - as groundbreaking treatment 'transforms' life for those with brain damage ... - Daily Mail - April 15th, 2024
- Consumer Alert on Regenerative Medicine Products Including Stem Cells - FDA.gov - April 13th, 2024
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market - Forbes - April 13th, 2024
- Brain-cell transplants are the newest experimental epilepsy treatment - MIT Technology Review - April 3rd, 2024
- Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86% CAGR: Astute ... - Yahoo Finance - April 1st, 2024
- Explosive Growth Projected for Stem Cell Market, Expected to Surpass $37 Billion by 2030 As Revealed In New... - WhaTech - April 1st, 2024
- Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma - Targeted Oncology - April 1st, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - Medical Xpress - March 30th, 2024
- The ISSCR announces 2024 election results - EurekAlert - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Charles River Extends Gene Therapy Alliance with NUS Medicine - Contract Pharma - March 22nd, 2024
- Exciting opportunities in stem cell technology and regenerative biology in Indian healthcare industry - Express Healthcare - March 22nd, 2024
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine - Yahoo Finance - March 22nd, 2024
- Opinion: The revolutionary sickle cell therapies - MSN - March 22nd, 2024
- 10 Years of Kansas Regenerative Medicine Center - KSAL - March 22nd, 2024
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership - Diagnostic and Interventional Cardiology - March 17th, 2024
- Cynata Therapeutics' breakthrough in regenerative medicine - Finance News Network - March 17th, 2024
- New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia - GlobeNewswire - March 17th, 2024
- Novel 3D stem cell therapy to treat critical limb ischaemia - Drug Target Review - March 15th, 2024
- Breaking Boundaries: Pharmicell's Bold Vision for Healthcare Transformation and Monumental Growth - The Worldfolio - March 15th, 2024
- CuSTOM Organoid Research Evolving From Tool to Treatment - Research Horizons - Research Horizons - March 15th, 2024
- BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart - Cath Lab Digest - March 15th, 2024
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine ... - Business Wire - March 13th, 2024
- Iron restriction keeps blood stem cells young, researchers find - Phys.org - March 13th, 2024
- Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues - March 9th, 2024
- Trends in Stem Cell Transplantation Refusal for Myeloma Treatment - Targeted Oncology - March 7th, 2024
- Stem Cell Therapy Market (CAGR) of 31.1%, Future of Market Size Emerging Technologies and their Impact on ... - Taiwan News - March 7th, 2024
- This Swedish startup wants to reduce the cost, and controversy, around stem cell production - TechCrunch - March 6th, 2024
- Advancing stem cell therapy: The regulatory process to get to clinical trials - The Economic Times - March 6th, 2024
- Transitioning from traditional surgical methods to the innovative use of stem cells - pharmaphorum - March 6th, 2024
- 'Mini organs' are grown from human stem cells taken during the late stages of pregnancy for the first time - m - Daily Mail - March 6th, 2024
- Stem cell transplant cures man of HIV and leukemia, one of five to achieve full remission - Fox 28 - March 3rd, 2024
- Stem Cell Therapy Market to Boost USD 137.5 Billion by 2034 and Projected to grow at 32.10% CAGR with increasing ... - Yahoo Finance - March 1st, 2024
- Studies expand use of stem cell therapies - WPLG Local 10 - March 1st, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Unlocking the Potential of Stem Cells: The Medical Revolution of the Century - EIN News - February 27th, 2024
- Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine ... - Yahoo Finance - February 27th, 2024
- Say Her Name - Henrietta Lacks, The Real Mother Of Stem - Her Campus - February 27th, 2024
- California Man Free of HIV And Cancer in Astonishing Medical Recovery - ScienceAlert - February 25th, 2024
- $93 million for research into improved health for children, young people and the aged, medical devices, mental health ... - Department of Health - February 25th, 2024
- Stem Cells in Regenerative Medicine - PMC - National Center for ... - February 24th, 2024
- The Promise and Reality of Stem Cell Therapy: What You Need to Know - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy: A Beacon of Hope for Patients with Untreatable Conditions - Corporate Wellness Magazine - February 22nd, 2024
- Leading Experts in Stem Cell Therapy: A Global Overview - Corporate Wellness Magazine - February 22nd, 2024
- Can Stem Cells Help Reverse the Effects of Aging? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy for Cancer: Hope on the Horizon? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cells and Autism: A Closer Look at Innovative Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Regrowth and Restoration: The Science Behind Stem Cell Therapy for Hair - Corporate Wellness Magazine - February 22nd, 2024
- Brain Recovery: The Role of Stem Cells in Stroke and Cerebral Palsy Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Turning Back the Clock: The Science of Stem Cells in Anti-Aging - Corporate Wellness Magazine - February 22nd, 2024
- Insights into cellular therapies for cancer treatment - Drug Target Review - February 22nd, 2024
- The Role of Stem Cells in Rheumatoid Arthritis Recovery - Corporate Wellness Magazine - February 22nd, 2024
- Dr Ernesto Romeros vision transforms immunotherapy regenerative medicine into a global leader in stem cell treatment - Khaleej Times - February 22nd, 2024
- World-Renowned Doctors Leading the Way in Stem Cell Research and Treatment - Medical Tourism Magazine - February 20th, 2024
- Choosing the Best: A Guide to America's Premier Stem Cell Therapy Providers - Medical Tourism Magazine - February 20th, 2024
- Navigating Through the Possibilities of Stem Cell Treatment for Eye Disorders - Medical Tourism Magazine - February 20th, 2024
- Global Leaders in Stem Cell Therapy: Where Excellence Meets Innovation - Medical Tourism Magazine - February 20th, 2024
- Excellence in Stem Cell Treatment: How the US is Pioneering Global Healthcare Solutions - Medical Tourism Magazine - February 20th, 2024
- Clarifying Memory Loss Treatments: The Role of Stem Cells - Medical Tourism Magazine - February 20th, 2024
- Battling Inflammation: Stem Cell Therapy for Rheumatoid Arthritis - Medical Tourism Magazine - February 20th, 2024
- Digestive Health and Stem Cells: Treating Ulcerative Colitis and Crohn's Disease - Medical Tourism Magazine - February 20th, 2024
- Top Stem Cell Clinics in the USA: Pioneering Treatments for Chronic Conditions - Medical Tourism Magazine - February 20th, 2024
- Stem Cells and Autism: Understanding the Potential for Innovative Treatments - Medical Tourism Magazine - February 20th, 2024
- Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse - University of Birmingham - February 20th, 2024
- City of Hope Achieves Ground Breaking Treatment for Blood Cancer and HIV - Medriva - February 18th, 2024
- Regenerative Medicine Market Size to Worth USD 95 Billion by 2032 - InvestorsObserver - February 18th, 2024
- North America Organoids Market Projected to Reach US$ 5.35 Billion by 2030, Riding on a CAGR of 21.5% - GlobeNewswire - February 18th, 2024
- Chinese team tests lung treatment that may be first to reverse COPD damage - South China Morning Post - February 15th, 2024
Recent Comments